If it has Lilly on the box, thats the goal we have. The GLP-1 market has expanded from under $12 billion in 2022 to a roughly $65 billion annualized run rate by mid-2025
However, since the clinical efficacy of GLP-1RA drugs in ocular diseases is a newly emerging area of research, direct clinical evidence and higher-level trials are still lacking
In comparison, Ozempic and Wegovy cost $1,000 to $1,300 for a monthly supply
FDA Safety Alerts on Compounded Semaglutide Dosing According to 20242025 FDA safety communications, the agency has received reports of adverse eventsincluding hospitalizationsthat may be related to dosing errors with compounded semaglutide products
GLP-1 reduces endoplasmic reticulum stress and apoptosis induced by hyperglycaemia and regulates mitochondrial function via stimulation of optic atrophy protein 1 [69]
The medication reduces the biological barriers to weight loss while you build the behavioral and lifestyle foundation that will support your new weight long-term